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The Ir genes were originally  postulated to have a role in antigen recognition by the T 
lymphocyte (1).  Antisera were produced in/r-incompatible recombinant strain combina- 
tions  in  an attempt to  identify  their gene product serologically  (2,  3).  The antisera reacted 
weakly or not at all with normal thymocytes, and their  reaction with normal spleen and 
lymph node cells  was found to be predominantly against B cells  (4, 5). This result was 
unexpected, and the association of  these antigens (later  designated Ia, reference 6) with 
the Ir gene products was questioned.  Further data suggested that at least some Ia 
antigens are also  expressed on T cells  (7).  More recently, it seems evident that Ir gene 
expression occurs in both T and B cells  (8) and in some cases two Ir genes appear to be 
involved in  the control  of  a specific  response (9,  10).  It  has been suggested that one of  these 
genes might control a T-cell "signal" and the other a B-cell accepter for the signal. 
Furthermore, it  has been shown that optimal collaborations between T and B cells  occur 
only in syngeneic combinations and genes determining this interaction were shown to 
map in the  I region (11).  Since the Ia antigens are thus implicated as possible  candidates 
for  the molecular recognition between T and B cells,  we undertook to investigate further 
the expression of  individual la specificities  on the two cell  populations utilizing  mitogen- 
induced blast  cells  from spleen, lymph node, and thymus. 
Materials and Methods 
All mice used in this study were raised in our colony at the University of Michigan. Anti-Thy- 
1.2 and anti-Ly.4.2 were kindly provided by Dr. J. A. Frelinger. A battery of anti-Ia sera (Table I) 
detecting Ia specificities 1-10 was produced in our laboratory, as previously described (2). The dye 
exclusion  microcytotoxic  test  and  5~Cr-release  cytotoxic  assay  were  performed  as  previously 
described (2). In vitro absorptions were done by incubating 50 k of antiserum, diluted to give 80% of 
maximum cytotoxicity,  with decreasing numbers of lymphocytes,  starting from 50  x  10  e cells. 
Antibody was eluted from the washed, sensitized cells by incubating for 20 rain at room tempera- 
ture  in  saline  acidified  to  pH  3.0  with  0.1  N  HC1.  The  suspension  was  centrifuged  and  the 
supernate decanted and neutralized (pH 7.0) with 0.004 N  NaOH (12). 
Lymphoid  cell  cultures  were  prepared  in  the  following  way.  Spleens,  lymph  nodes,  and 
thymuses  were  removed  from  COs-asphyxiated  animals and  transferred  to  chilled  Dulbecco's 
medium  (Ca ++  and Mg  ++ free).  Care  was taken to  avoid  parathymic nodes  in the  thymus by 
liberating the organ from the capsular tissue before preparation of the cell suspension. Tissues 
were gently homogenized with a  loose-fitting teflon pestle and rapidly filtered through a  nylon 
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TABLE  I 
List of Antisera Used 
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Antisera  Specificities detected 
Reagent no.  Recipient  Donor  H-2  Ia 
1  A.TH  A.TL  --  1,2,3,7 
2  A.TL  A.TH  ~  4,5,[anti-Tla] 
3  [B10.A(4R)  × HT1]F~  B10.A  --  6 
4  [HTH  x C3H.Q]F~  C3H.B10  33  8 
5  [A  x  B10.D2]F~  B10.A(5R)  33  9 
6  [A.CA x B10.HTT]F~  A.TL  --  2,3 
7  IA.BY x B10.HTTIF~  A.TL  ~  1,2 
8  [A.TL x A.TFR 3]F~  A.TH  --  4 
9  [B10.A(4R)  x  HT1]F~  B10.A(5R)  ~  7 
10  A.AKR  A.AL  Thy-l.2 
11  AKR  C3H  Thy-l.2,...., 
12  IBALB/c x SWR]F~  B10.D2  Ly-4.2 
wool-packed syringe. The suspensions  were pelleted at 600 g  for 10 min, washed twice, and diluted 
to 15 ×  106 viable cells per ml of culture medium consisting  of 25 mM HEPES-buffered RPMI-1640, 
containing 2.5% fetal calf serum, antibiotic-antimycotic preparation (Gibco, Grand Island Biologi- 
cal Co.,  Grand Island, N.  Y.),  30 ~M 2-mercaptoethanol, and 20 mM L-glutamine. Suspensions 
were aliquoted, 7.5 ml per petri dish (60  x  15 ram, Falcon Plastics, Oxnard, Calif.), and pulsed 
with mitogen. Conconavalin A (Con A) (A grade, Calbiochem, Los Angeles, Calif.) was used at 5 
~g/ml final concentration, lipepolysaccharide (LPS) (310-25 Bacto Escherichia coli OSS: BS, Difco 
Laboratories, Detroit,  Mich.) at 100 pg/ml, and pokeweed mitogen (PWM) (Gibco N536) at 1:50 
dilution of reconstituted lyophilized preparation.  Cultures were incubated at 37°C  in an atmos- 
phere of 95% air and 5% CO2. 
Results and Discussion 
Splenic Blasts.  LPS-stimulated spleen cells yielded 80-100% blasts by visual 
inspection at termination  of the culture. Viable blast cells were separated from 
dead cells by layering on Ficoll-isopaque.  The results obtained when blasts of 
haplotypes H-2 ~ and H-28 were typed with a battery of anti-Ia sera in the ~Cr 
cytotoxic release assay are shown in Table II. Anti-H-2, anti-Thy-l.2,  and anti- 
Ly.4.2 sera were tested in parallel  as controls.  LPS-stimulated blasts reacted 
with anti-Ia sera at titers similar to those with normal spleen cells, but usually 
gave 10-20% higher 51Cr release. 
Con A-stimulated splenic lymphocytes gave approximately 60-70% lysis with 
anti-Thy-1  serum,  suggesting that they were enriched  in T  cells.  Anti-Ia sera 
gave variable reactions with these blasts. Against B10.K (Ia k) targets,  all anti- 
A.TL (Ia k) sera gave good reactions.  B10.S Con A  blasts gave strong reactions 
with anti-Ia.4,5,  but very weak reactions with antisera  to Ia.9.  These results 
suggested that Ia antigens are expressed not only on splenic LPS (B-cell) blasts, 
but also on splenic Con A blasts (which are T cells), although not as strongly. In 
general,  homologous antisera  gave stronger reactions than antisera  detecting 
cross-reacting specificities. 
Thymic Blasts.  Thymic  lymphocytes, prepared  with care to exclude para- 
thymic lymph node cells, were stimulated with PWM, Con A, and LPS.  PWM 
and Con A-stimulated thymocytes yielded 70-100% blasts. LPS failed to stimu- 
late detectable blast formation in thymocyte cultures,  indicating lack of B-cell 220  DAVID  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE II 
Cytotoxic Titers (5'Cr Assay) of Mitogen-Induced Spleen Blasts* 
Antisera 
Target Cells 
B10.K  (H-2 k)  B10.S (H-2') 
(Ia.1,2,3,7,15)  (Ia.4,5,9,12) 
No.  Antibody  LPS  Con A  LPS  Con A 
1  Anti-la. 1,2,3,7  >160(++)  >160(+)  --  -- 
6  "  2,3  >160(++)  >160(+)  --  -- 
7  "  1,2  >160(+ +)  >160(+)  --  -- 
9  7  >160(+ +)  >160(±)  --  -- 
2  "  4,5  --  --  >160(++)  >160(+) 
5  9  --  --  >160(+ +)  20(-  +) 
10  "  Thy-l.2  0  >160(++)  0  >160(++) 
12  Ly-4.2  >160( + +)  20(±)  >160(+ +)  20(-  +) 
(-), not  tested; (+  +), 20-40% release above base line;  (+), 10-20% release above abase line;  (-+),  5-10% release 
above base line. 
* ~'Cr release assay-reciprocal  of  titer. 
contamination.  Anti-Thy-I  reacted with 70-90% of normal  thymocytes and  of 
PWM and Con A-stimulated blasts.  Normal thymocytes gave only trace reac- 
tions with anti-Ia sera. LPS-treated thymocytes failed to react with anti-Ia sera, 
again  suggesting  that  there  were no  contaminant  B  cells  in the  thymic  cell 
population. The results of these tests are shown in Table III. BIO.A(H-2 a) blasts 
gave strong reactions with antisera to Ia.1,2,3, and 7 and a weak reaction with 
anti-Ia.6. B10.S(H-2') blasts gave strong reactions for Ia.4,5, but a weak reaction 
for Ia.9.  BIO.D2(H-2 d) blasts gave strong reactions with anti-Ia.6  and 7 and a 
weak reaction for Ia.8. These results again suggest that Ia antigens detected by 
cross-reacting antisera give weak reactions.  However, there is no doubt that Ia 
antigens are expressed on T cells and are easily detectable on mitogen-activated 
T cells. 
The reactions of [B10.A × B10.S]F, (H-2a/H-2 s) thymic blasts with anti-Ia and 
control sera are shown in Fig. 1. Normal serum gave about 10% lysis, compared 
to anti-H-2.19,  which gave 100% lysis and a titer greater than 2,560.  Anti-Thy- 
1.2 (A.AL [Thy-l.1] anti-A.AL [Thy-l,2]) gave 90% lysis with a titer of about 320. 
Anti-Thy-l.2  produced in  a  noncongenic combination  (AKR anti-C3H)  gave a 
titer greater than 2,560 with 100% lysis. A.TH anti-A.TL  (Ia k) and A.TL anti- 
A.TH  (/a')  sera  gave  65-75%  cell  lysis.  A  mixture  of the  two antisera  gave 
slightly higher cell lysis, but not sufficient to suggest allelic exclusion of the Ia 
antigens detected. Anti-Ia.9,  antiserum (B10.D2  x  A)F, anti-B10.A(5R), gave a 
maximum  of only 50%  lysis,  again  indicating  the  weaker reactivity of cross- 
reacting antibodies. 
Lymph Node Blasts.  Lymph node lymphocytes were stimulated with Con A 
and  LPS.  Lymph node  Con  A  blasts  reacted  very much like  thymus  Con  A 
blasts, while lymph node LPS blasts reacted like splenic LPS blasts. Both types 
of blasts expressed all of the Ia specificit!es studied. 
Absorptions.  Cross-absorptions were performed with Con A-stimulated thy- 
mocytes (T-Con A),  Con A-stimulated lymph node cells (LN-Con A),  and LPS 
stimulated  spleen cells (S-LPS) using  strain  A.TL mice and  antiserum  A.TH 
anti-A.TL  (Anti-Ia.l,2,3,7)  (Fig.  2).  LN-Con  A  cells  (T  blasts)  and  S-LPS (B T
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['BIO,  A x BIO.S]¢~  THYMUS BLASTS 
~"~""-.,~=~  onli-H-2 
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W  anti- Io.9  a.  ~,, 
2C 
Normal Serum Control 
0  0  0  0 
I/5  1/10  1/20  1/40  1/80  1/160  1/320  1/640  ~"256@ 
ANTISERUM DILUTION 
FIG. i.  Target cell  [BI0.A x BI0.S]F~ thymus blasts.  Direct cytotoxic  reaction with anti- 
H-2, anti-Thy-I and anti-la. 
blasts) absorbed completely for each other, suggesting that the Ia specificities 
expressed on those two populations of cells are very similar or identical. T-Con A 
cells absorbed the antiserum less efficiently and less completely for LN-Con A 
and S-LPS blast target cells. This could be interpreted in two ways: (a) T-Con A 
blasts have a  much lower density of one or more of the Ia specificities involved 
and (b) T-Con A blasts lack one or more of the specificities defined by the A.TH 
anti-A.TL sera. Conceivably, there could be two closely linked genes specifying 
two discrete antigens, one predominantly on T cells, the other predominantly on 
B cells. The two antigens could have different functional roles, e.g. one as the T- 
cell signal and the other as the B-cell receptor for that signal. 
Absorption-Elution.  Antiserum A.TH  anti-A.TL was  absorbed  onto LPS- 
stimulated  spleen  cells  from  B10  (Ia.3),  A.CA(Ia.1),  and  B10.D2(Ia.7).  The 
lymphocytes were washed,  and the  antibody was eluted from the cells.  The 
eluted antibodies reacted strongly with Con A-induced thymus blasts from the 
donor A.TL, suggesting expression of Ia.l,3, and 7 on both T and B blasts. The 
eluted anti-Ia. 1 and anti-Ia.3 reacted only weakly with A.CA and B10 thymus- 
Con A blasts, again suggesting strong affinity of the antibody against T cells of 
the homologous strain compared to the cross-reacting strain. Anti-Ia.7 did not 
show such a difference, suggesting a common origin of Ia.7 in H-2 k and H-2 ~. DAVID  ET  AL.  BRIEF  DEFINITIVE  REPORT  223 
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FIG. 2.  A.TH anti-A.TL absorbed with A.TL Con A thymus blasts  (@".'e),  A.TL Con A 
lymph node blasts  (O  ©), and A.TL spleen  LPS blasts  ([5---0) and tested  against 
lymph node-Con A blasts  and spleen  LPS blasts. 
There is  a possibility  that mitogen-stimulated blast cells  might express some 
viral protein. Mouse H-2 and Ia alloantisera are known to contain antiviral 
activity (P. Klein, personal communication).  Therefore, the anti-la sera could 
conceivably be  reacting with a viral  antigen on  the  blast  cells  rather  than with  Ia 
antigens. There are  several lines  of  evidence against this  possibility:  (a)  Negative 
control antisera which are known to have antiviral  activity  did not give lysis  of 
blast  cells.  (b)  Antibody eluted from normal spleen cells  lacks viral  activity,  but 
gave typical lysis  with appropriate blast  targets. (c) Absorption with thymus 
blasts removes antibody activity  against normal spleen cells,  which should be 
due to specific  anti-la  antibodies, since normal spleen cells  do not express viral 
antigens. 
Summary 
Ia specificities 1-10 were detected on LPS-stimulated splenic lymphocytes and 
on Con A-stimulated spleen, lymph node, and thymus blasts by direct cytotoxic 
tests.  Since Ia antigens  are  not readily detectable on resting thymocytes, our 
results suggest that T cells require some signal before they exhibit full expres- 
sion of Ia specificities. Absorption-elution studies indicated that most of the Ia 
specificities detected on T and B cells may be identical.  Ia antigens detected by 
homologous antisera gave much stronger reactions than those detected by cross- 
reacting antisera. 224  DAVID  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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